Stock Comparison

BEAM vs VRTX

Beam Therapeutics Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

BEAM

Beam Therapeutics Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$3.58B

$124.70B

P/E (TTM)

—

29.2

Forward P/E

—

25.8

Price/Sales

21.8

10.2

Price/Book

3.1

6.4

EV/EBITDA

-7.0

24.0

Dividend Yield

—

Profitability

Net Margin

-40.20%

35.50%

Operating Margin

-337.80%

38.10%

Return on Equity

-5.77%

24.20%

Return on Assets

-15.80%

12.10%

Growth (YoY)

Revenue Growth

324.90%

7.80%

Earnings Growth

0.00%

61.40%

Price & Risk

Beta

2.2

0.3

52-Week High

$36.88

$507.92

52-Week Low

$15.60

$362.50

Analyst Target

$51.07

$548.69

Compare BEAM and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.